Citations

Mayo Clinic

Showing 10 of 108551 citations.

Prevalence and drivers of nurse and physician distress in cardiovascular and oncology programmes at a Canadian quaternary hospital network during the COVID-19 pandemic: a quality improvement initiative
Jelen, Ahlexxi , Rodin, Gary , Graham, Leanna, Goldfarb, Rebecca, Mah, Kenneth , Satele, Daniel , Krzyzanowska, Monika K. , Rubin, Barry B. , Satele, Daniel V, Rubin, Barry B , Elliot, Mary

BMJ Open | February 12, 2024 | Volume: 14 | Issue: 2 | Pages: e079106

10.1136/bmjopen-2023-079106 | PMID 38346886 Get It

Objectives To assess the prevalence and drivers of distress, a composite of burnout, decreased meaning in work, severe fatigue, poor work–life integration and quality of life, and suicidal ideation, among nurses and physicians during the COVID-19 pandemic. Design Cross-sectional design to evaluate distress levels of nurses and physicians during the COVID-19 pandemic between June and August 2021. Setting Cardiovascular and oncology care settings at a Canadian quaternary hospital network. Participants 261 nurses and 167 physicians working in cardiovascular or oncology care. Response rate was 29% (428 of 1480). Outcome measures Survey tool to measure clinician distress using the Well-Being Index (WBI) and additional questions about workplace-related and COVID-19 pandemic-related factors. Results Among 428 respondents, nurses (82%, 214 of 261) and physicians (62%, 104 of 167) reported high distress on the WBI survey. Higher WBI scores (≥2) in nurses were associated with perceived inadequate staffing (174 (86%) vs 28 (64%), p=0.003), unfair treatment, (105 (52%) vs 11 (25%), p=0.005), and pandemic-related impact at work (162 (80%) vs 22 (50%), p<0.001) and in their personal life (135 (67%) vs 11 (25%), p<0.001), interfering with job performance. Higher WBI scores (≥3) in physicians were associated with perceived inadequate staffing (81 (79%) vs 32 (52%), p=0.001), unfair treatment (44 (43%) vs 13 (21%), p=0.02), professional dissatisfaction (29 (28%) vs 5 (8%), p=0.008), and pandemic-related impact at work (84 (82%) vs 35 (56%), p=0.001) and in their personal life (56 (54%) vs 24 (39%), p=0.014), interfering with job performance. Conclusion High distress was common among nurses and physicians working in cardiovascular and oncology care settings during the pandemic and linked to factors within and beyond the workplace. These results underscore the complex and contextual aspects of clinician distress, and the need to develop targeted approaches to effectively address this problem.
Neuro-Ophthalmic Literature Review
Bellows, David A., Chen, John J. , Cheng, Hui‐Chen , MacIntosh, Peter W., Vaphiades, Michael S., Chen, John J , Chan, Noel C. Y. , Zhang, Xiaojun

Neuro-Ophthalmology | February 12, 2024 | Volume: 48 | Issue: 1 | Pages: 65-71

10.1080/01658107.2023.2291987 Get It

Use of perceptual memory as a performance validity indicator: initial validation with simulated mild traumatic brain injury
Basso, Michael R. , Guzmán, Daniel , Hoffmeister, Jordan , Mulligan, Ryan , Whiteside, Douglas M. , Combs, Dennis R. , Combs, Dennis , Whiteside, Douglas

Journal of Clinical and Experimental Neuropsychology | February 12, 2024 | Volume: 46 | Issue: 1 | Pages: 55-66

10.1080/13803395.2024.2314991 | PMID 38346160 Get It

Deep-RSIv2: An Efficient Content-Free Deep Learning Approach for Radiographs' Manufacturer and Model Identification
Mohammadi, Farid Ghareh , Sebro, Ronnie

2024 18th International Conference on Ubiquitous Information Management and Communication (IMCOM) | February 12, 2024 | Volume: No volume available | Issue: No issue available | Pages: 1-8

10.1109/imcom60618.2024.10418243 Get It

Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy
Hamnvik, Ole‐Petter R. , Davidge‐Pitts, Caroline , Ariel, Danit , Abramowitz, Jessica , Soe, Kyaw , Sarvaideo, Jenna , Kelley, Carly E. , Hamnvik, Ole-Petter R , Iwamoto, Sean J , Rothman, Micol Sara , Safer, Joshua D. , Tangpricha, Vin , Irwig, Michael S. , Iwamoto, Sean J.

Transgender Health | February 12, 2024 | Volume: 9 | Issue: 6 | Pages: 463-465

10.1089/trgh.2023.0209 | PMID 39735380 Get It

Injectable estrogens are options for gender-affirming hormone therapy per guidelines, which suggest intramuscular dosages of 5–30 mg every 2 weeks or 2–10 mg weekly with estradiol cypionate or valerate interchangeably. Data among transgender and gender-diverse patients are limited due to local unavailability and concerns around laboratory assay variability and estradiol (E2) level fluctuation. We note a concerning trend where patients are prescribed high-dose injections based on the guidelines leading to serum E2 levels well above the range recommended in the same guidelines. Our review indicates that 5 mg weekly or lower should be prescribed when initiating injectable estrogens to avoid supraphysiologic E2 levels.
Mitochondrial myopathies diagnosed in adulthood: clinico-genetic spectrum and long-term outcomes
Beecher, Grayson , Gavrilova, Ralitza H. , Mandrekar, Jay , Naddaf, Elie , Naddaf, Elie , Beecher, Grayson

Brain Communications | February 12, 2024 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcae041 | PMID 38434220 Get It

Abstract Mitochondrial myopathies are frequently recognized in childhood as part of a broader multisystem disorder and often overlooked in adulthood. Herein, we describe the phenotypic and genotypic spectrum and long-term outcomes of mitochondrial myopathies diagnosed in adulthood, focusing on neuromuscular features, electrodiagnostic and myopathological findings and survival. We performed a retrospective chart review of adult patients diagnosed with mitochondrial myopathy at Mayo Clinic (2005–21). We identified 94 patients. Median time from symptom onset to diagnosis was 11 years (interquartile range 4–21 years). Median age at diagnosis was 48 years (32–63 years). Primary genetic defects were identified in mitochondrial DNA in 48 patients (10 with single large deletion, 38 with point mutations) and nuclear DNA in 29. Five patients had multiple mitochondrial DNA deletions or depletion without nuclear DNA variants. Twelve patients had histopathological features of mitochondrial myopathy without molecular diagnosis. The most common phenotypes included multisystem disorder (n = 30); mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (14); limb myopathy (13); chronic progressive external ophthalmoplegia (12); and chronic progressive external ophthalmoplegia-plus (12). Isolated skeletal muscle manifestations occurred in 27%. Sixty-nine per cent had CNS and 21% had cardiac involvement. Mutations most frequently involved MT-TL1 (27) and POLG (17); however, a wide spectrum of established and novel molecular defects, with overlapping phenotypes, was identified. Electrodiagnostic studies identified myopathy (77%), fibrillation potentials (27%) and axonal peripheral neuropathy (42%, most common with nuclear DNA variants). Among 42 muscle biopsies available, median percentage counts were highest for cytochrome C oxidase negative fibres (5.1%) then ragged blue (1.4%) and ragged red fibres (0.5%). Skeletal muscle weakness was mild and slowly progressive (decline in strength summated score of 0.01/year). Median time to gait assistance was 5.5 years from diagnosis and 17 years from symptom onset. Thirty patients died, with median survival of 33.4 years from symptom onset and 10.9 years from diagnosis. Median age at death was 55 years. Cardiac involvement was associated with increased mortality [hazard ratio 2.36 (1.05, 5.29)]. There was no difference in survival based on genotype or phenotype. Despite the wide phenotypic and genotypic spectrum, mitochondrial myopathies in adults share similar features with slowly progressive limb weakness, contrasting with common multiorgan involvement and high mortality.
Health AI Assurance Laboratories—Reply
Anderson, Brian, Shah, Nigam H. , Halamka, John

JAMA | February 12, 2024 | Volume: 331 | Issue: 12 | Pages: 1062

10.1001/jama.2024.1087 | PMID 38345790 Get It

Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)
Fussner, Lynn A. , Flores-Suárez, Luis Felipe , Cartin‐Ceba, Rodrigo , Specks, Ulrich , Cox, Gerard , Jayne, David , Merkel, Peter A. , Walsh, Michael , Moreland, Larry W. , Little, Mark A. , Johnson, David W. , Nachman, Patrick H. , Barratt, Jonathan , Bech, Jesper Nørgaard , Badve, Sunil V. , Jones, Rachel , Pavenski, Katerina , Cox, P Gerard , Jayne, David , Moreland, Larry W , Johnson, David W , Specks, Ulrich , Merkel, Peter A , Barratt, Jonathan , Birn, Henrik , Pavenski, Katerina

American Journal of Respiratory and Critical Care Medicine | February 12, 2024 | Volume: 209 | Issue: 9 | Pages: 1141-1151

10.1164/rccm.202308-1426oc | PMID 38346237 Get It

Abstract Rationale Diffuse alveolar hemorrhage (DAH) is a life-threatening manifestation of antineutrophil cytoplasmic antibody–associated vasculitis (AAV). The PEXIVAS (Plasma Exchange and Glucocorticoids in Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis) (NCT00987389) trial was the largest in AAV and the first to enroll participants with DAH requiring mechanical ventilation. Objectives Evaluate characteristics, treatment effects, and outcomes for patients with AAV with and without DAH. Methods PEXIVAS randomized 704 participants to plasma exchange (PLEX) or no-PLEX and reduced or standard-dose glucocorticoids (GC). DAH status was defined at enrollment as no-DAH, nonsevere, or severe (room air oxygen saturation of ≤ 85% as measured by pulse oximetry, or use of mechanical ventilation). Measurements and Main Results At enrollment, 191 (27.1%) participants had DAH (61 severe, including 29 ventilated) and were younger, more frequently relapsing, PR3 (proteinase 3)-ANCA positive, and had lower serum creatinine but were more frequently dialyzed than participants without DAH (n = 513; 72.9%). Among those with DAH, 8/95 (8.4%) receiving PLEX died within 1 year versus 15/96 (15.6%) with no-PLEX (hazard ratio, 0.52; confidence interval [CI], 0.21–1.24), whereas 13/96 (13.5%) receiving reduced GC died versus 10/95 (10.5%) with standard GC (hazard ratio, 1.33; CI, 0.57–3.13). When ventilated, ventilator-free days were similar with PLEX versus no-PLEX (medians, 25; interquartile range [IQR], 22–26 vs. 22–27) and fewer with reduced GC (median, 23; IQR, 20–25) versus standard GC (median, 26; IQR, 25–28). Treatment effects on mortality did not vary by presence or severity of DAH. Overall, 23/191 (12.0%) with DAH died within 1 year versus 34/513 (6.6%) without DAH. End-stage kidney disease and serious infections did not differ by DAH status or treatments. Conclusions Patients with AAV and DAH differ from those without DAH in multiple ways. Further data are required to confirm or refute a benefit of PLEX or GC dosing on mortality. Original clinical trial registered with www.clinicaltrials.gov (NCT00987389).
Persistent B Cell–Derived MHC Class II Signaling Is Required for the Optimal Maintenance of Tissue-Resident Helper T Cells
Son, Young Min , Cheon, In Su , Li, Chaofan , Sun, Jie , Sun, Jie , Li, Chaofan

ImmunoHorizons | February 12, 2024 | Volume: 8 | Issue: 2 | Pages: 163-171

10.4049/immunohorizons.2300093 | PMID 38345472 Get It

Abstract Emerging studies have identified the critical roles of tissue-resident memory CD8+ T (TRM) and B (BRM) cells in the protection against mucosal viral infections, but the underlying mechanisms regulating robust development of TRM and BRM cells remain incompletely understood. We have recently shown that tissue-resident helper CD4+ T (TRH) cells, developed following influenza virus infection, function to sustain the optimal maintenance of TRM and BRM cells at the mucosal surface. In this study, we have explored the cellular and molecular cues modulating lung TRH persistence after influenza infection in C57BL/6 mice. We found that TRH cells were colocalized in tertiary lymphoid structures (TLSs) with local B cells. Abolishing TLSs or the depletion of B cells impaired lung TRH cell numbers. Of note, we found that persistent TCR signaling is needed for the maintenance of TRH cells after the clearance of infectious influenza virus. Furthermore, selective ablation of B cell–derived MHC class II resulted in partial reduction of lung TRH cell number after influenza infection. Our findings suggest that the interaction between lung-resident TRH cells and B cells, along with persistent Ag stimulation, is required to maintain TRH cells after respiratory viral infection.
Integrated Feedforward and Feedback Mechanisms in Neurovascular Coupling
Meng, Lingzhong , Rasmussen, Mads , Meng, Deyi M., White, Fletcher A. , Wu, Long‐Jun , Wu, Long-Jun

Anesthesia & Analgesia | February 12, 2024 | Volume: 139 | Issue: 6 | Pages: 1283-1293

10.1213/ane.0000000000006891 | PMID 38345932 Get It

Neurovascular coupling (NVC) is the mechanism that drives the neurovascular response to neural activation, and NVC dysfunction has been implicated in various neurologic diseases. NVC is driven by (1) nonmetabolic feedforward mechanisms that are mediated by various signaling pathways and (2) metabolic feedback mechanisms that involve metabolic factors. However, the interplay between these feedback and feedforward mechanisms remains unresolved. We propose that feedforward mechanisms normally drive a swift, neural activation–induced regional cerebral blood flow (rCBF) overshoot, which floods the tissue beds, leading to local hypocapnia and hyperoxia. The feedback mechanisms are triggered by the resultant hypocapnia (not hyperoxia), which causes cerebral vasoconstriction in the neurovascular unit that counterbalances the rCBF overshoot and returns rCBF to a level that matches the metabolic activity. If feedforward mechanisms function improperly (eg, in a disease state), the rCBF overshoot, tissue-bed flooding, and local hypocapnia fail to occur or occur on a smaller scale. Consequently, the neural activation–related increase in metabolic activity results in local hypercapnia and hypoxia, both of which drive cerebral vasodilation and increase rCBF. Thus, feedback mechanisms ensure the brain milieu’s stability when feedforward mechanisms are impaired. Our proposal integrates the feedforward and feedback mechanisms underlying NVC and suggests that these 2 mechanisms work like a fail-safe system, to a certain degree. We also discussed the difference between NVC and cerebral metabolic rate-CBF coupling and the clinical implications of our proposed framework.